| Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis Nature 476 (7359), 214-219, 2011 | 2948 | 2011 |
| Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis International IBD Genetics Consortium (IIBDGC), C Agliardi, L Alfredsson, ... Nature genetics 45 (11), 1353-1360, 2013 | 1325 | 2013 |
| Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility International Multiple Sclerosis Genetics Consortium*†, ANZgene, ... Science 365 (6460), eaav7188, 2019 | 840 | 2019 |
| Variation in interleukin 7 receptor α chain (IL7R) influences risk of multiple sclerosis F Lundmark, K Duvefelt, E Iacobaeus, I Kockum, E Wallström, M Khademi, ... Nature genetics 39 (9), 1108-1113, 2007 | 621 | 2007 |
| Class II HLA interactions modulate genetic risk for multiple sclerosis Nature genetics 47 (10), 1107-1113, 2015 | 390 | 2015 |
| Overexpression of the cytokine BAFF and autoimmunity risk M Steri, V Orrù, ML Idda, M Pitzalis, M Pala, I Zara, C Sidore, V Faà, ... New England Journal of Medicine 376 (17), 1615-1626, 2017 | 378 | 2017 |
| Glutamate decarboxylase-, insulin-, and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children. WA Hagopian, CB Sanjeevi, I Kockum, M Landin-Olsson, AE Karlsen, ... The journal of clinical investigation 95 (4), 1505-1511, 1995 | 338 | 1995 |
| Smoking and two human leukocyte antigen genes interact to increase the risk for multiple sclerosis AK Hedström, E Sundqvist, M Bäärnhielm, N Nordin, J Hillert, I Kockum, ... Brain 134 (3), 653-664, 2011 | 314 | 2011 |
| Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course M Khademi, I Kockum, ML Andersson, E Iacobaeus, L Brundin, ... Multiple Sclerosis Journal 17 (3), 335-343, 2011 | 299 | 2011 |
| Genetic effects on age-dependent onset and islet cell autoantibody markers in type 1 diabetes J Graham, WA Hagopian, I Kockum, LS Li, CB Sanjeevi, RM Lowe, ... Diabetes 51 (5), 1346-1355, 2002 | 292 | 2002 |
| Interaction between adolescent obesity and HLA risk genes in the etiology of multiple sclerosis AK Hedström, I Lima Bomfim, L Barcellos, M Gianfrancesco, C Schaefer, ... Neurology 82 (10), 865-872, 2014 | 273 | 2014 |
| Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study P Benkert, S Meier, S Schaedelin, A Manouchehrinia, Ö Yaldizli, ... The Lancet Neurology 21 (3), 246-257, 2022 | 252 | 2022 |
| Epstein-Barr virus and multiple sclerosis: interaction with HLA E Sundqvist, P Sundström, M Lindén, AK Hedström, F Aloisi, J Hillert, ... Genes & Immunity 13 (1), 14-20, 2012 | 222 | 2012 |
| Mendelian randomization shows a causal effect of low vitamin D on multiple sclerosis risk B Rhead, M Bäärnhielm, M Gianfrancesco, A Mok, X Shao, H Quach, ... Neurology: Genetics 2 (5), e97, 2016 | 220 | 2016 |
| Hydrogeochemical changes before and after a major earthquake L Claesson, A Skelton, C Graham, C Dietl, M Mörth, P Torssander, ... Geology 32 (8), 641-644, 2004 | 212 | 2004 |
| Relative predispositional effects of HLA class II DRB1‐DQB1 haplotypes and genotypes on type 1 diabetes: a meta‐analysis G Thomson, AM Valdes, JA Noble, I Kockum, MN Grote, J Najman, ... Tissue antigens 70 (2), 110-127, 2007 | 210 | 2007 |
| Changes in groundwater chemistry before two consecutive earthquakes in Iceland A Skelton, M Andrén, H Kristmannsdóttir, G Stockmann, CM Mörth, ... Nature Geoscience 7 (10), 752-756, 2014 | 207 | 2014 |
| Heredity of hypospadias and the significance of low birth weight L Fredell, I Kockum, E Hansson, S Holmner, L Lundquist, G Läckgren, ... The Journal of urology 167 (3), 1423-1427, 2002 | 197 | 2002 |
| Multiple sclerosis-associated IL2RA polymorphism controls GM-CSF production in human TH cells FJ Hartmann, M Khademi, J Aram, S Ammann, I Kockum, ... Nature communications 5 (1), 5056, 2014 | 191 | 2014 |
| Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod F Piehl, I Kockum, M Khademi, K Blennow, J Lycke, H Zetterberg, ... Multiple Sclerosis Journal 24 (8), 1046-1054, 2018 | 189 | 2018 |
